- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/713 - Double-stranded nucleic acids or oligonucleotides
Patent holdings for IPC class A61K 31/713
Total number of patents in this class: 6929
10-year publication summary
513
|
602
|
535
|
618
|
618
|
589
|
585
|
778
|
592
|
138
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Alnylam Pharmaceuticals, Inc. | 1066 |
367 |
Arrowhead Pharmaceuticals, Inc. | 216 |
114 |
Dicerna Pharmaceuticals, Inc. | 278 |
96 |
The Regents of the University of California | 18943 |
88 |
University of Massachusetts | 2130 |
82 |
Nitto Denko Corporation | 7879 |
78 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
70 |
Ionis Pharmaceuticals, Inc. | 776 |
63 |
Centre National de La Recherche Scientifique | 9632 |
46 |
Regeneron Pharmaceuticals, Inc. | 3650 |
45 |
The General Hospital Corporation | 4517 |
43 |
Arbutus Biopharma Corporation | 183 |
42 |
Novartis AG | 11238 |
39 |
CuRNA, Inc. | 147 |
37 |
The Johns Hopkins University | 5377 |
36 |
Immunomedics, Inc. | 290 |
36 |
City of Hope | 943 |
33 |
Northwestern University | 3112 |
32 |
Osaka University | 3143 |
31 |
Massachusetts Institute of Technology | 9795 |
30 |
Other owners | 5521 |